SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MARCHETTI, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.129
EU - Europa 2.582
AS - Asia 1.914
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 3
SA - Sud America 1
Totale 13.641
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.099
CN - Cina 983
UA - Ucraina 707
DE - Germania 561
TR - Turchia 415
IT - Italia 393
SG - Singapore 391
GB - Regno Unito 281
SE - Svezia 217
FI - Finlandia 152
PL - Polonia 91
BE - Belgio 41
HK - Hong Kong 41
ID - Indonesia 35
FR - Francia 31
CZ - Repubblica Ceca 30
RU - Federazione Russa 30
CA - Canada 27
NL - Olanda 15
IN - India 14
VN - Vietnam 12
IR - Iran 10
IE - Irlanda 6
JP - Giappone 6
AU - Australia 4
CH - Svizzera 4
EU - Europa 4
LT - Lituania 4
PT - Portogallo 4
MX - Messico 3
NZ - Nuova Zelanda 3
RO - Romania 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
DZ - Algeria 2
GR - Grecia 2
HU - Ungheria 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
DK - Danimarca 1
IL - Israele 1
KR - Corea 1
MA - Marocco 1
MK - Macedonia 1
MT - Malta 1
RS - Serbia 1
Totale 13.641
Salva come PNG Salva come JPEG
Città #
Fairfield 1.044
Woodbridge 1.044
Chandler 780
Jacksonville 773
Houston 756
Ann Arbor 622
Ashburn 545
Seattle 428
Wilmington 406
Cambridge 378
Singapore 280
Izmir 257
Nanjing 242
Boardman 178
Princeton 171
Beijing 144
Ferrara 133
New York 130
San Diego 107
Warsaw 90
Milan 81
Shanghai 70
Nanchang 69
Shenyang 68
Dearborn 63
Bremen 62
Hebei 57
Tianjin 47
San Mateo 45
Jiaxing 44
Düsseldorf 43
Santa Clara 43
Los Angeles 42
Changsha 40
Brussels 38
Falls Church 38
Hong Kong 36
Munich 36
Jakarta 35
Jinan 32
Kunming 30
Addison 28
Norwalk 28
Redwood City 28
Brno 27
London 24
Auburn Hills 22
Des Moines 19
Mountain View 19
Zhengzhou 17
Ningbo 15
Guangzhou 14
Augusta 13
Helsinki 13
Rome 13
Dong Ket 12
Mcallen 12
Orange 12
Toronto 12
Washington 12
Hangzhou 11
Taizhou 11
Indiana 10
Philadelphia 10
Verona 10
Leawood 8
Montréal 8
Ardabil 7
Florence 7
Haikou 7
Lanzhou 7
Monmouth Junction 7
Padova 7
Amsterdam 6
Frankfurt am Main 6
Hounslow 6
Ottawa 6
Redmond 6
Fuzhou 5
Taiyuan 5
Castelcovati 4
Changchun 4
Hanover 4
Hefei 4
Nutley 4
Pune 4
Sala 4
Shenzhen 4
Tappahannock 4
Bologna 3
Dublin 3
Lusia 3
Mülheim-kärlich 3
Pregassona 3
Albignasego 2
Asti 2
Athens 2
Atlanta 2
Auckland 2
Catania 2
Totale 10.080
Salva come PNG Salva come JPEG
Nome #
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 193
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 185
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 149
Hemostasis biomarkers in multiple sclerosis 148
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 142
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 140
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 134
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 134
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 127
null 125
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 124
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 123
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 123
Taqi polymorphism at the human coagulation factor XII locus (F12) 122
null 121
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 121
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 120
Plasma levels of soluble NCAM in multiple sclerosis 119
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease. 118
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 117
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 116
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 114
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 114
Membrane binding and anticoagulant properties of protein S natural variants 113
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 113
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 113
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 112
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 112
Partial gene deletion in a family with factor X deficiency 111
Detection and characterization of polymorphic markers in the factor-VII gene. 109
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 108
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 107
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 107
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 106
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 106
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 106
PRIMARY INTRAVASCULAR SYNOVIAL SARCOMA OF THE FEMORAL VEIN IN A MALE PATIENT, CASE REPORT 105
Factor VII mutant V154G models a zymogen-like form of factor VIIa 104
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 103
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 103
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 102
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 102
Human leukemia K562 cells: Relationship between hemin-mediated erythroid induction, cell proliferation and expression of c-abl and c-myc oncogenes 101
null 100
Clinical picture and management of congenital factor VII deficiency 99
Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene. 99
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 99
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 98
Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381-->Ser) in the substrate-binding pocket 98
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 98
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 98
Risks factors for highly unstable response to oral anticoagulation: a case-control study 97
null 96
null 96
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 95
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 95
null 95
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 95
PCR and specific oligonucleotide hybridization for the molecular characterization and carrier detection of hemophilia A. 95
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 95
null 94
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 93
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 93
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 92
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 92
Protein S mRNA in patients with protein S deficiency. 91
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) 90
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 89
Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII 88
2 TAQI RFLPS IN THE HUMAN VONWILLEBRAND-FACTOR GENE 88
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 88
In-Frame Deletion of von Willebrand Factor Exons 26-34 (D3-A3 Domains) in Type II von Willebrand Disease. 87
null 86
Modulation of thrombophilia genes by environmental factors 85
Sublocalization of von Willebrand Factor Pseudogene in 22q11.22-q11.23 and Detection of two TaqI RFLPs. 85
c-myc oncogene alterations in human thyroid carcinomas. 84
Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region 83
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 83
null 82
β+-thalassaemia in the Po river delta region (northern Italy): Genotype and β globin synthesis 80
DECAY OF BETA-GLOBIN SYNTHESIS IN HETEROZYGOUS BETA-O-FERRARA THALASSEMIA 80
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 80
CHROMOSOMAL LOCALIZATION AND CHARACTERIZATION OF RFLPs IN THE VON WILLEBRAND FACTOR PSEUDOGENE 80
2 ADDITIONAL TAQI RFLPS IN VONWILLEBRAND-FACTOR GENE (VWF) AND PSEUDOGENE 80
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 80
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 80
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 79
Two novel mutations (Pro864His, Val867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28. 79
Localization of cloned human DNA sequences and analysis of chromosomal alterations by in situ hybridization. 79
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 78
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 78
Molecular Characteristics of a Non-deletion α-Thalassaemia of the Po River Delta 78
Molecular genetics and biology of congenital hemorrhagic diseases 77
Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma 77
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 77
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 76
Two mutations causing complete androgen insensitivity: a frame-shift in the steroid binding domain and a Cys→Phe substitution in the second zinc finger of the androgen receptor 75
ALPHA-THALASSEMIA TRAIT IN THE REGION OF FERRARA 74
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 73
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 73
Totale 10.126
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 527
Totale 63.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.114 0 0 0 385 165 344 222 285 206 341 103 63
2020/20212.223 195 189 148 252 64 202 118 243 58 320 313 121
2021/20221.826 115 191 130 111 114 64 73 80 53 129 153 613
2022/20231.766 189 123 45 215 282 289 74 165 221 14 91 58
2023/2024924 69 91 34 32 64 191 20 62 23 20 24 294
2024/2025530 93 66 295 76 0 0 0 0 0 0 0 0
Totale 13.845